Journal of Functional Biomaterials (Jul 2022)

Injectable, Anti-Cancer Drug-Eluted Chitosan Microspheres against Osteosarcoma

  • Jiebing Zhao,
  • Hao Tian,
  • Fusheng Shang,
  • Tao Lv,
  • Dagui Chen,
  • Jianjun Feng

DOI
https://doi.org/10.3390/jfb13030091
Journal volume & issue
Vol. 13, no. 3
p. 91

Abstract

Read online

The purpose of this study is to fabricate different anti-cancer drug-eluted chitosan microspheres for combination therapy of osteosarcoma. In this study, electrospray in combination with ground liquid nitrogen was utilized to manufacture the microspheres. The size of obtained chitosan microspheres was uniform, and the average diameter was 532 μm. The model drug release rate and biodegradation rate of chitosan microspheres could be controlled by the glutaraldehyde vapor crosslinking time. Then the 5-fluorouracil (5-FU), paclitaxel (PTX), and Cis-dichlorodiammine-platinum (CDDP) eluted chitosan microspheres were prepared, and two osteosarcoma cell lines, namely, HOS and MG-63, were selected as cell models for in vitro demonstration. We found the 5-FU microspheres, PTX microspheres, and CDDP microspheres could significantly inhibit the growth and migration of both HOS and MG-63 cells. The apoptosis of both cells treated with 5-FU microspheres, PTX microspheres, and CDDP microspheres was significantly increased compared to the counterparts of control and blank groups. The anti-cancer drug-eluted chitosan microspheres show great potential for the treatment of osteosarcoma.

Keywords